References
- Castleman B, Iverson L, Menendez V P. Localized mediastinal lymph-node hyperplasia resembling thymoma. Cancer 1956; 9: 822–30
- Frizzera G. Castleman's disease: more questions than answers. Hum Pathol 1985; 16: 202–5
- Sharp G C. Diagnostic criteria for classification of MCTD. Mixed connective tissue disease and anti-nuclear antibodies, R Kasukawa, G C Sharp. Elsevier Science Publishers B.V., Amsterdam 1987; 23–32
- Nakanishi T, Sobue I, Toyokura Y, Nishitani H, Kuroiwa Y, Satoyoshi E, et al. The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology 1984; 34: 712–20
- Weisenburger D D, Nathwani B N, Winberg C D, Rappaport H. Multicentric angiofollicular lymph node hyperplasia: a clinicopahologic study of 16 cases. Hum Pathol 1985; 16: 162–72
- Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 1989; 74: 1360–7
- Brandt S J, Bodine D M, Dunbar C E, Nienhuis A W. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest 1990; 86: 592–9
- Mandler R N, Kerrigan D P, Smart J, Kuis W, Villiger P, Lotz M. Castleman's disease in POEMS syndrome with elevated interleukin-6. Cancer 1992; 69: 2697–703
- Kishimoto T. The biology of interleukin-6. Blood 1989; 74: 1–10
- Hirano T, Taga T, Yasukawa K, Nakajima K, Nakano N, Tokatsuki F, et al. Human B-cell differentiation factor defined by anti-peptide antibody and its possible role in autoantibody production. Proc Natl Acad Sci USA 1987; 84: 228–31
- Tavoni A, Vitali C, Baglioni P, Gerli R, Marchetti G, Di Munno O, et al. Multicentric Castleman's disease in a patient with primary Sjögren's syndrome. Rheumatol Int 1993; 12: 251–3
- Ben-Chetrit E, Flusser D, Okon E, Ackerman Z, Rubinow A. Multicentric Castleman's disease associated with rheumatoid arthritis: a possible role of hepatitis B antigen. Ann Rheum Dis 1989; 48: 326–30
- Marsh J H, Colbourn D S, Donovan V, Staszewski H. Systemic Castleman's disease in association with Evan's syndrome and vitiligo. Med Pediatr Oncol 1990; 18: 169–72
- Calin A, Elswood J, Klouda P T. Destructive arthritis, rheumatoid factor, and HLA-DR4. Susceptibility versus severity, a case-control study. Arthritis Rheum 1989; 32: 1221–5
- Kurosawa S, Kimura O, Sagawa A. Systemic lupus erythematosus in a patient with the 47,XXX karyotype. Arthritis Rheum 1991; 34: 371–2